Waystar (WAY) versus Its Competitors Head to Head Survey

Waystar (NASDAQ:WAY) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it contrast to its peers? We will compare Waystar to related businesses based on the strength of its dividends, risk, profitability, analyst recommendations, earnings, institutional ownership and valuation.

Analyst Ratings

This is a breakdown of current ratings and price targets for Waystar and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0	4	17	2	2.91
Waystar Competitors	454	1535	2745	89	2.51

Waystar currently has a consensus target price of $35.23, indicating a potential upside of 22.15%. As a group, “Healthcare Technology” companies have a potential upside of 42.16%. Given Waystar’s peers higher possible upside, analysts clearly believe Waystar has less favorable growth aspects than its peers.

Institutional and Insider Ownership

42.4% of shares of all “Healthcare Technology” companies are owned by institutional investors. 3.5% of Waystar shares are owned by insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Waystar has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500. Comparatively, Waystar’s peers have a beta of 1.11, suggesting that their average stock price is 11% more volatile than the S&P 500.

Valuation and Earnings

This table compares Waystar and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Waystar	$1.26 billion	$112.09 million	41.80
Waystar Competitors	$347.07 million	-$24.15 million	13.10

Waystar has higher revenue and earnings than its peers. Waystar is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Waystar and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Waystar	10.70%	6.91%	4.67%
Waystar Competitors	-751.03%	-29.63%	-15.45%

Summary

Waystar beats its peers on 9 of the 13 factors compared.

About Waystar

Waystar provides cloud-based healthcare payment and revenue cycle management software. Its platform helps healthcare organizations manage administrative and financial processes, including claims submission, payment processing, patient billing, and revenue collection. The company’s products support providers in identifying and addressing claim denials, checking patient eligibility, estimating costs, collecting payments, and analyzing revenue cycle performance. Waystar serves a range of healthcare organizations, including hospitals, health systems, physician groups, and other medical providers, primarily in the United States.